FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steven Sherman

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Thyroid Gland

Co-author Network

Publications

TOP 3
Steven I Sherman
The role of recombinant human thyrotropin for diagnostic monitoring of patients with differentiated thyroid cancer.
Aubrey A Carhill; Robert F Gagel; Mouhammed Amir Habra; Mimi Hu; Camilo Jimenez; Steven I Sherman; Rena Vassilopoulou-Sellin; Steven G Waguespack; Anita Ying; Maria Cabanillas; Naifa L Busaidy
The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoring.
Steven I Sherman
Emerging treatments in thyroid cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steven Sherman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Steven I Sherman
The role of recombinant human thyrotropin for diagnostic monitoring of patients with differentiated thyroid cancer.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2013;19(1):157-61.
2013: Aubrey A Carhill; Robert F Gagel; Mouhammed Amir Habra; Mimi Hu; Camilo Jimenez; Steven I Sherman; Rena Vassilopoulou-Sellin; Steven G Waguespack; Anita Ying; Maria Cabanillas; Naifa L Busaidy
The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoring.
The Journal of clinical endocrinology and metabolism 2013;98(1):31-42.
2012: Steven I Sherman
Emerging treatments in thyroid cancer.
Clinical advances in hematology & oncology : H&O 2012;10(9):594-6.
2012: Jacqueline Jonklaas; Paul W Ladenson; D Litofsky; J Magner; Harry R Maxon; M Munsell; G Nogueras-Gonzalez; Jacob Robbins; Douglas S Ross; Steven I Sherman; Monica C Skarulis; D L Steward; Kenneth B Ain; S Thomas Bigos; James D Brierley; David S Cooper; Bryan R Haugen
The impact of age and gender on papillary thyroid cancer survival.
The Journal of clinical endocrinology and metabolism 2012;97(6):E878-87.
2012: Mauricio A Moreno; Steven I Sherman; Eric Siegel; Beth S Edeiken-Monroe; Gary L Clayman
In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival.
Thyroid : official journal of the American Thyroid Association 2012;22(4):347-55.
2012: Maria E Cabanillas; Steven I Sherman
Applying new clinicopathological characteristics to prognostication in advanced thyroid carcinoma.
Endocrine-related cancer 2012;19(2):C19-22.
2011: Gary L Clayman; Beth S Edeiken; Dianna B Roberts; Garima Agarwal; Steven G Waguespack; Steven I Sherman
Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma.
Thyroid : official journal of the American Thyroid Association 2011;21(12):1309-16.
2011: Razelle Kurzrock; Ranee Mehra; Thomas Müller; Forlisa Nauling; Chaan S Ng; David G Pfister; Mark J Ratain; Douglas W Ball; Ezra E W Cohen; Roger B Cohen; Arlene A Forastiere; John Frye; Robert F Gagel; David S Hong; Linda Janisch; Steven I Sherman; Lei Ye; Ravi Salgia
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(19):2660-6.
2011: Steven I Sherman
Targeted therapies for thyroid tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24 Suppl 2():S44-52.
2011: David S Hong; Maria Cabanillas; Jennifer Wheler; Aung Naing; Apostolia-Maria Tsimberidou; Lei Ye; Steven G Waguespack; Mike Hernandez; Adel K El Naggar; Savita Bidyasar; John Wright; Steven I Sherman; Naifa L Busaidy; Alder K El Naggar; Razelle Kurzrock
Inhibition of the Ras/Raf/MEK/ERK and RET kinase pathways with the combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid malignancies.
The Journal of clinical endocrinology and metabolism 2011;96(4):997-1005.
2011: Mauricio A Moreno; Garima Agarwal; Rolando de Luna; Eric Siegel; Steven I Sherman; Beth S Edeiken-Monroe; Gary L Clayman
Preoperative lateral neck ultrasonography as a long-term outcome predictor in papillary thyroid cancer.
Archives of otolaryngology--head & neck surgery 2011;137(2):157-62.
2010: R Michael Tuttle; Douglas W Ball; David Byrd; Raza A Dilawari; Gerard M Doherty; Quan-Yang Duh; Hormoz Ehya; William B Farrar; Robert I Haddad; Fouad Kandeel; Richard T Kloos; Peter Kopp; Dominick M Lamonica; Thom R Loree; William M Lydiatt; Judith C McCaffrey; John Olson; Lee Parks; John A Ridge; Jatin P Shah; Steven I Sherman; Cord Sturgeon; Steven G Waguespack; Thomas N Wang; Lori J Wirth
Thyroid carcinoma.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(11):1228-74.
2010: Aarti Bhatia; Archana Rao; Kie-Kian Ang; Adam S Garden; William H Morrison; David I Rosenthal; Douglas B Evans; Gary L Clayman; Steven I Sherman; David L Schwartz
Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy.
Head & neck 2010;32(7):829-36.
2010: Libero Santarpia; Jeffrey N Myers; Steven I Sherman; Francesco Trimarchi; Gary L Clayman; Adel K El-Naggar
Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.
Cancer 2010;116(12):2974-83.
2010: Maria Cabanillas; Steven G Waguespack; Yulia Bronstein; Michelle D Williams; Lei Feng; Mike Hernandez; Adriana Lopez; Steven I Sherman; Naifa L Busaidy
Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience.
The Journal of clinical endocrinology and metabolism 2010;95(6):2588-95.
2010: R Michael Tuttle; Douglas W Ball; David Byrd; Gilbert H Daniels; Raza A Dilawari; Gerard M Doherty; Quan-Yang Duh; Hormoz Ehya; William B Farrar; Robert I Haddad; Fouad Kandeel; Richard T Kloos; Peter Kopp; Dominick M Lamonica; Thom R Loree; William M Lydiatt; Judith McCaffrey; John Olson; Lee Parks; John A Ridge; Jatin P Shah; Steven I Sherman; Cord Sturgeon; Steven G Waguespack; Thomas N Wang; Lori J Wirth
Medullary carcinoma.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(5):512-30.
2010: Erich M Sturgis; Steven I Sherman
Should papillary thyroid carcinoma be observed?: a word of caution.
Archives of otolaryngology--head & neck surgery 2010;136(5):444-6.
2009: Martin Schlumberger; Steven I Sherman
Clinical trials for progressive differentiated thyroid cancer: patient selection, study design, and recent advances.
Thyroid : official journal of the American Thyroid Association 2009;19(12):1393-400.
2009: Steven I Sherman
Tyrosine kinase inhibitors and the thyroid.
Best practice & research. Clinical endocrinology & metabolism 2009;23(6):713-22.
2009: David S Hong; Said M Sebti; Robert A Newman; Michelle A Blaskovich; Lei Ye; Robert F Gagel; Stacy Moulder; Jennifer J Wheler; Aung Naing; Nizar M Tannir; Chaan S Ng; Steven I Sherman; Adel K El-Naggar; Rabia Khan; Jonathan Trent; John J Wright; Razelle Kurzrock
Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(22):7061-8.
2009: Marshall Tulloch-Reid; Monica C Skarulis; Steven I Sherman; Nicholas Sarlis; Libero Santarpia
Long-term eradication of locally recurrent invasive follicular thyroid carcinoma after taxane-based concomitant chemoradiotherapy.
Anticancer research 2009;29(11):4665-71.
2009: David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
Thyroid : official journal of the American Thyroid Association 2009;19(11):1167-214.
2009: Rossella Elisei; Martin Schlumberger; A Driedger; Christoph Reiners; Richard T Kloos; Steven I Sherman; Bryan R Haugen; Carine Corone; Eleonora Molinaro; Lucia Grasso; sophie leboulleux; I Rachinsky; Markus Luster; Michael Lassmann; N L Busaidy; Richard L Wahl; Furio Pacini; Steve Y Cho; J Magner; Aldo Pinchera; Paul W Ladenson
Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.
The Journal of clinical endocrinology and metabolism 2009;94(11):4171-9.
2009: Apostolia-Maria Tsimberidou; Christos Vaklavas; Sijin Wen; David Hong; Jennifer Wheler; Chaan Ng; Aung Naing; Susan Tse; Naifa L Busaidy; Maurie Markman; Steven I Sherman; Razelle Kurzrock
Phase I clinical trials in 56 patients with thyroid cancer: the M. D. Anderson Cancer Center experience.
The Journal of clinical endocrinology and metabolism 2009;94(11):4423-32.
2009: Douglas S Ross; Danielle Litofsky; Kenneth B Ain; Thomas Bigos; James D Brierley; David S Cooper; Bryan R Haugen; Jacqueline Jonklaas; Paul W Ladenson; James Magner; Jacob Robbins; Monica C Skarulis; David L Steward; Harry R Maxon; Steven I Sherman
Recurrence after treatment of micropapillary thyroid cancer.
Thyroid : official journal of the American Thyroid Association 2009;19(10):1043-8.
2009: Steven I Sherman
Molecularly targeted therapies for thyroid cancers.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2009;15(6):605-11.
2009: Gary L Clayman; Thomas D Shellenberger; Lawrence E Ginsberg; Beth S Edeiken; Adel K El-Naggar; Rena V Sellin; Steven G Waguespack; Dianna B Roberts; Anupam Mishra; Steven I Sherman
Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma.
Head & neck 2009;31(9):1152-63.
2009: Martin J Schlumberger; Rossella Elisei; Lars Bastholt; Lori J Wirth; Renato G Martins; Laura D Locati; Barbara Jarzab; Furio Pacini; Chantal Daumerie; Jean-Pierre Droz; Michael J Eschenberg; Yu-Nien Sun; Todd Juan; Daniel E Stepan; Steven I Sherman
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(23):3794-801.
2009: Grace L Smith; Benjamin David Smith; Adam S Garden; David I Rosenthal; Steven I Sherman; William H Morrison; David L Schwartz; Randal S Weber; Thomas A Buchholz
Hypothyroidism in older patients with head and neck cancer after treatment with radiation: a population-based study.
Head & neck 2009;31(8):1031-8.
2009: David L Schwartz; Mark J Lobo; K Kian Ang; William H Morrison; David I Rosenthal; Anesa Ahamad; Douglas B Evans; Gary L Clayman; Steven I Sherman; Adam S Garden
Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment.
International journal of radiation oncology, biology, physics 2009;74(4):1083-91.
2009: Libero Santarpia; Steven I Sherman; Anna Marabotti; Gary L Clayman; Adel K El-Naggar
Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma.
Human pathology 2009;40(6):827-33.
2009: Manal M Hassan; Ahmed Kaseb; Donghui Li; Yehuda Z Patt; Jean-Nicolas Vauthey; Melanie Thomas; Steven A Curley; Margaret R Spitz; Steven I Sherman; Eddie K Abdalla; Marta Davila; Richard D Lozano; Deena M Hassan; Wenyaw Chan; Thomas D Brown; James L Abbruzzese
Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States.
Hepatology (Baltimore, Md.) 2009;49(5):1563-70.
2009: Steven I Sherman
Advances in chemotherapy of differentiated epithelial and medullary thyroid cancers.
The Journal of clinical endocrinology and metabolism 2009;94(5):1493-9.
2009: Steven G Waguespack; Steven I Sherman; Michelle D Williams; Gary L Clayman; Cynthia E Herzog
The successful use of sorafenib to treat pediatric papillary thyroid carcinoma.
Thyroid : official journal of the American Thyroid Association 2009;19(4):407-12.
2009: sophie leboulleux; PAMELA SCHROEDER; N L Busaidy; Anne Auperin; Carine Corone; Heather A Jacene; Marge Ewertz; Claire Bournaud; Richard L Wahl; Steven I Sherman; Paul W Ladenson; Martin Schlumberger
Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancer.
The Journal of clinical endocrinology and metabolism 2009;94(4):1310-6.
2009: Libero Santarpia; Robert Gagel; Steven I Sherman; Nicholas Sarlis; Douglas B Evans; Ana O Hoff
Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer.
Head & neck 2009;31(3):419-23.
2008: Libero Santarpia; Adel K El-Naggar; Steven I Sherman; Sharon R Hymes; Robert Gagel; Stephanie Shaw; Nicholas Sarlis
Four patients with cutaneous metastases from medullary thyroid cancer.
Thyroid : official journal of the American Thyroid Association 2008;18(8):901-5.
2008: Steven I Sherman; Lori J Wirth; Jean Pierre Droz; Michael Hofmann; Lars Bastholt; Renato G Martins; Lisa Licitra; Michael J Eschenberg; Yu-Nien Sun; Todd Juan; Daniel E Stepan; Martin J Schlumberger
Motesanib diphosphate in progressive differentiated thyroid cancer.
The New England journal of medicine 2008;359(1):31-42.
2008: David L Schwartz; Vishal Rana; Stephanie Shaw; Cynthia Yazbeck; K. Kian Ang; William H Morrison; David I Rosenthal; Ana O Hoff; Douglas B Evans; Gary L Clayman; Adam S Garden; Steven I Sherman
Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era.
Head & neck 2008;30(7):883-8.
2008: Steven I Sherman
Early clinical studies of novel therapies for thyroid cancers.
Endocrinology and metabolism clinics of North America 2008;37(2):511-24, xi.
2008: Libero Santarpia; Adel K El-Naggar; Gilbert J Cote; Jeffrey N Myers; Steven I Sherman
Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer.
The Journal of clinical endocrinology and metabolism 2008;93(1):278-84.
2008: Danielle D Elliott; Steven I Sherman; Naifa L Busaidy; Michelle D Williams; Libero Santarpia; Gary L Clayman; Adel K El-Naggar
Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification.
Human pathology 2008;39(1):15-20.
2007: Libero Santarpia; Nicholas Sarlis; Mariacarmela Santarpia; Steven I Sherman; Francesco Trimarchi; Salvatore Benvenga
Mosaicism in von Hippel-Lindau disease: an event important to recognize.
Journal of cellular and molecular medicine 2007;11(6):1408-15.
2007: Steven I Sherman
New approaches to therapy of thyroid malignancies.
Clinical advances in hematology & oncology : H&O 2007;5(7):539-41.
2007: Steven I Sherman; Peter Angelos; Douglas W Ball; David Byrd; Orlo H Clark; Gilbert H Daniels; Raza A Dilawari; Hormoz Ehya; William B Farrar; Robert Gagel; Fouad Kandeel; Richard T Kloos; Peter Kopp; Dominick M Lamonica; Thom R Loree; William M Lydiatt; Judith McCaffrey; John Olson; John A Ridge; Jatin P Shah; James C Sisson; R Michael Tuttle; Marshall M Urist
Thyroid carcinoma.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(6):568-621.
2007: Steven I Sherman
Can serum thyroglobulin levels predict patient outcome after treatment of differentiated thyroid carcinoma?
Nature clinical practice. Endocrinology & metabolism 2007;3(7):510-1.
2007: Wendy M Golden; Katie B Weber; Teri L Hernandez; Steven I Sherman; Whitney W Woodmansee; Bryan R Haugen
Single-dose rexinoid rapidly and specifically suppresses serum thyrotropin in normal subjects.
The Journal of clinical endocrinology and metabolism 2007;92(1):124-30.
2006: Jacqueline Jonklaas; Nicholas Sarlis; Danielle Litofsky; Kenneth B Ain; S Thomas Bigos; James D Brierley; David S Cooper; Bryan R Haugen; Paul W Ladenson; James Magner; Jacob Robbins; Douglas S Ross; Monica C Skarulis; Harry R Maxon; Steven I Sherman
Outcomes of patients with differentiated thyroid carcinoma following initial therapy.
Thyroid : official journal of the American Thyroid Association 2006;16(12):1229-42.
2006: Mary C Frates; Carol B Benson; J William Charboneau; Edmund S Cibas; Orlo H Clark; Beverly G Coleman; John J Cronan; Peter M Doubilet; Douglas B Evans; John R Goellner; Ian D Hay; Barbara S Hertzberg; Charles M Intenzo; R Brooke Jeffrey; Jill E Langer; P Reed Larsen; Susan J Mandel; William D Middleton; Carl C Reading; Steven I Sherman; Franklin N Tessler
Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement.
Ultrasound quarterly 2006;22(4):231-8; discussion 239-40.
2006: Farah Ghori; Kristel D Polder; Lauren Pinter-Brown; Ana O Hoff; Robert Gagel; Steven I Sherman; Madeleine Duvic
Thyrotoxicosis after denileukin diftitox therapy in patients with mycosis fungoides.
The Journal of clinical endocrinology and metabolism 2006;91(6):2205-8.
2006: Ewa Mrozek; Richard T Kloos; Matthew D Ringel; Laura Kresty; Paulette Snider; Daria Arbogast; Merrill Kies; Reginald Munden; Naifa Busaidy; Mary Jean Klein; Steven I Sherman; Manisha H Shah
Phase II study of celecoxib in metastatic differentiated thyroid carcinoma.
The Journal of clinical endocrinology and metabolism 2006;91(6):2201-4.
2006: Heribert Hänscheid; Michael Lassmann; Markus Luster; Stephen R Thomas; Furio Pacini; Claudia Ceccarelli; Paul W Ladenson; Richard L Wahl; Martin Schlumberger; Marcel Ricard; Al Driedger; Richard T Kloos; Steven I Sherman; Bryan R Haugen; Vincent Carriere; Carine Corone; Christoph Reiners
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(4):648-54.
2006: PAMELA SCHROEDER; Bryan R Haugen; Furio Pacini; Christoph Reiners; Martin Schlumberger; Steven I Sherman; David S Cooper; Kathryn G Schuff; Lewis E Braverman; Monica C Skarulis; terry Davies; Ernest L Mazzaferri; Gilbert H Daniels; Douglas S Ross; Markus Luster; Mary H Samuels; Bruce D Weintraub; E Chester Ridgway; Paul W Ladenson
A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal.
The Journal of clinical endocrinology and metabolism 2006;91(3):878-84.
2006: David S Cooper; Gerard M Doherty; Bryan R Haugen; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Steven I Sherman; R Michael Tuttle
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
Thyroid : official journal of the American Thyroid Association 2006;16(2):109-42.
2005: Mary C Frates; Carol B Benson; J William Charboneau; Edmund S Cibas; Orlo H Clark; Beverly G Coleman; John J Cronan; Peter M Doubilet; Douglas B Evans; John R Goellner; Ian D Hay; Barbara S Hertzberg; Charles M Intenzo; R Brooke Jeffrey; Jill E Langer; P Reed Larsen; Susan J Mandel; William D Middleton; Carl C Reading; Steven I Sherman; Franklin N Tessler
Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement.
Radiology 2005;237(3):794-800.
2005: Maria A Kouvaraki; Suzanne E Shapiro; Nancy D Perrier; Gilbert J Cote; Robert Gagel; Ana O Hoff; Steven I Sherman; Jeffrey E Lee; Douglas B Evans
RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors.
Thyroid : official journal of the American Thyroid Association 2005;15(6):531-44.
2005: Steven I Sherman; Peter Angelos; Douglas W Ball; Samuel W Beenken; David Byrd; Orlo H Clark; Gilbert H Daniels; Raza A Dilawari; Hormoz Ehya; William B Farrar; Robert Gagel; Fouad Kandeel; Richard T Kloos; Peter Kopp; Dominick M Lamonica; Thom R Loree; William M Lydiatt; Judith McCaffrey; John Olson; John A Ridge; Richard Robbins; Jatin P Shah; James C Sisson; Norman W Thompson
Thyroid carcinoma.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(3):404-57.
2004: Bradley Schiff; Andrea B McMurphy; Samar A Jasser; Maher N Younes; Dao Doan; Orhan G Yigitbasi; Seungwon Kim; Ge Zhou; Mahitosh Mandal; B Nebiyou Bekele; F Christopher Holsinger; Steven I Sherman; Sai-Ching Jim Yeung; Adel K El-Naggar; Jeffrey N Myers
Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8594-602.
2004: Maria A Kouvaraki; Jeffrey E Lee; Suzanne E Shapiro; Steven I Sherman; Douglas B Evans
Preventable reoperations for persistent and recurrent papillary thyroid carcinoma.
Surgery 2004;136(6):1183-91.
2004: Naifa L Busaidy; Camilo Jimenez; Mouhammed Amir Habra; Pamela N Schultz; Adel K El-Naggar; Gary L Clayman; Joshua A Asper; Eduardo M Diaz; Douglas B Evans; Robert Gagel; Adam Garden; Ana O Hoff; Jeffrey E Lee; William H Morrison; David I Rosenthal; Steven I Sherman; Erich M Sturgis; Steven G Waguespack; Randal S Weber; Kelly Wirfel; Rena Vassilopoulou-Sellin
Parathyroid carcinoma: a 22-year experience.
Head & neck 2004;26(8):716-26.
2004: Linwah Yip; Jeffrey E Lee; Suzanne E Shapiro; Steven G Waguespack; Steven I Sherman; Ana O Hoff; Robert Gagel; James F Arens; Douglas B Evans
Surgical management of hereditary pheochromocytoma.
Journal of the American College of Surgeons 2004;198(4):525-34; discussion 534-5.
2003: Lee C Pederson; Suzanne E Shapiro; Herbert A Fritsche; Ebrahim S Delpassand; Robert Gagel; Steven I Sherman; Rena Vassilopoulou-Sellin; Douglas B Evans; Jeffrey E Lee
Potential role for intraoperative gamma probe identification of normal parathyroid glands.
American journal of surgery 2003;186(6):711-7.
2003: Guido M Sclabas; Gregg Staerkel; Suzanne E Shapiro; Bruno D Fornage; Steven I Sherman; Rena Vassillopoulou-Sellin; Jeffrey E Lee; Douglas B Evans
Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients.
American journal of surgery 2003;186(6):702-9; discussion 709-10.
2003: Maria A Kouvaraki; Suzanne E Shapiro; Bruno D Fornage; Beth S Edeiken-Monro; Steven I Sherman; Rena Vassilopoulou-Sellin; Jeffrey E Lee; Douglas B Evans
Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer.
Surgery 2003;134(6):946-54; discussion 954-5.
2003: Tina W F Yen; Suzanne E Shapiro; Robert Gagel; Steven I Sherman; Jeffrey E Lee; Douglas B Evans
Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients.
Surgery 2003;134(6):890-9; discussion 899-901.
2003: Todd R Shepler; Steven I Sherman; Misha Faustina; Naifa L Busaidy; M Amir Ahmadi; Bita Esmaeli
Nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma.
Ophthalmic plastic and reconstructive surgery 2003;19(6):479-81.
2003: Markus Luster; Steven I Sherman; Monica C Skarulis; James R Reynolds; Michael Lassmann; Heribert Hänscheid; Christoph Reiners
Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma.
European journal of nuclear medicine and molecular imaging 2003;30(10):1371-7.
2003: Linwah Yip; Gilbert J Cote; Suzanne E Shapiro; Gregory D Ayers; Cynthia E Herzog; Rena V Sellin; Steven I Sherman; Robert Gagel; Jeffrey E Lee; Douglas B Evans
Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship.
Archives of surgery (Chicago, Ill. : 1960) 2003;138(4):409-16; discussion 416.
2003: Ernest L Mazzaferri; R J Robbins; CA Spencer; Lewis E Braverman; Furio Pacini; Leonard Wartofsky; Bryan R Haugen; Steven I Sherman; David S Cooper; G D Braunstein; S Lee; terry Davies; Baha Arafah; Paul W Ladenson; A Pinchera
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.
The Journal of clinical endocrinology and metabolism 2003;88(4):1433-41.
2003: Steven I Sherman
Etiology, diagnosis, and treatment recommendations for central hypothyroidism associated with bexarotene therapy for cutaneous T-cell lymphoma.
Clinical lymphoma 2003;3(4):249-52.
2003: Luis Lopez-Penabad; Alice C Chiu; Ana O Hoff; Pamela Schultz; Sonia Gaztambide; Nelson G Ordoñez; Steven I Sherman
Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Cancer 2003;97(5):1186-94.
2003: Steven I Sherman
Thyroid carcinoma.
Lancet 2003;361(9356):501-11.
2002: Richard E Royal; Ebrahim S Delpassand; Suzanne E Shapiro; Herbert A Fritsche; Rena Vassilopoulou-Sellin; Steven I Sherman; Robert Gagel; Douglas B Evans; Jeffrey E Lee
Improving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression.
Surgery 2002;132(6):968-74; discussion 974-5.
2002: Farah Y Ghori; Danielle R Gutterman-Litofsky; Amin Jamal; Sai-Ching Jim Yeung; Ridha Arem; Steven I Sherman
Socioeconomic factors and the presentation, management, and outcome of patients with differentiated thyroid carcinoma.
Thyroid : official journal of the American Thyroid Association 2002;12(11):1009-16.
2002: Maria A Kouvaraki; Jeffrey E Lee; Suzanne E Shapiro; Robert Gagel; Steven I Sherman; Rena V Sellin; Gilbert J Cote; Douglas B Evans
Genotype-phenotype analysis in multiple endocrine neoplasia type 1.
Archives of surgery (Chicago, Ill. : 1960) 2002;137(6):641-7.
2001: Nestor F. Esnaola; Scott B Cantor; Steven I Sherman; Jeffrey E Lee; Douglas B Evans
Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis.
Surgery 2001;130(6):921-30.
2000: Steven I Sherman
The management of metastatic differentiated thyroid carcinoma.
Reviews in endocrine & metabolic disorders 2000;1(3):165-71.
1999: Bryan R Haugen; Furio Pacini; Christoph Reiners; Martin Schlumberger; Paul W Ladenson; Steven I Sherman; David S Cooper; KE Graham; Lewis E Braverman; Monica C Skarulis; terry Davies; L J DeGroot; Ernest L Mazzaferri; Gilbert H Daniels; Douglas S Ross; Markus Luster; Mary H Samuels; D V Becker; Harry R Maxon; R R Cavalieri; CA Spencer; K McEllin; Bruce D Weintraub; E Chester Ridgway
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.
The Journal of clinical endocrinology and metabolism 1999;84(11):3877-85.
1999: Jason Fleming; Jeffrey E Lee; Michael Bouvet; Pamela N Schultz; Steven I Sherman; Rena V Sellin; K E Friend; Michael A Burgess; Gilbert J Cote; Robert Gagel; Douglas B Evans
Surgical strategy for the treatment of medullary thyroid carcinoma.
Annals of surgery 1999;230(5):697-707.
1999: C D Sturgis; Nancy P Caraway; Dennis A Johnston; Steven I Sherman; L Kidd; Ruth Katz
Image analysis of papillary thyroid carcinoma fine-needle aspirates: significant association between aneuploidy and death from disease.
Cancer 1999;87(3):155-60.
1999: Ridha Arem; SJ Padayatty; A H Saliby; Steven I Sherman
Thyroid microcarcinoma: prevalence, prognosis, and management.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 1999;5(3):148-56.
1999: Steven I Sherman; J Gopal; Bryan R Haugen; Alice C Chiu; K Whaley; P Nowlakha; Madeleine Duvic
Central hypothyroidism associated with retinoid X receptor-selective ligands.
The New England journal of medicine 1999;340(14):1075-9.
1999: Steven I Sherman
Adjuvant therapy and long-term management of differentiated thyroid carcinoma.
Seminars in surgical oncology 1999;16(1):30-3.
1999: Steven I Sherman
Toward a standard clinicopathologic staging approach for differentiated thyroid carcinoma.
Seminars in surgical oncology 1999;16(1):12-5.
1998: Jeffrey E Lee; Douglas B Evans; R C Hickey; Steven I Sherman; Robert Gagel; MC Abbruzzese; James L Abbruzzese
Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas.
Surgery 1998;124(6):1115-22.
1998: Leonard Wartofsky; Steven I Sherman; J Gopal; M Schlumberger; I D Hay
The use of radioactive iodine in patients with papillary and follicular thyroid cancer.
The Journal of clinical endocrinology and metabolism 1998;83(12):4195-203.
1998: David S Cooper; B Specker; M Ho; M Sperling; Paul W Ladenson; Douglas S Ross; Kenneth B Ain; S Thomas Bigos; James D Brierley; Bryan R Haugen; I Klein; Jacob Robbins; Steven I Sherman; T Taylor; Harry R Maxon
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
Thyroid : official journal of the American Thyroid Association 1998;8(9):737-44.
1998: Steven I Sherman; James D Brierley; M Sperling; Kenneth B Ain; S Thomas Bigos; David S Cooper; Bryan R Haugen; M Ho; I Klein; Paul W Ladenson; Jacob Robbins; Douglas S Ross; B Specker; T Taylor; Harry R Maxon
Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group.
Cancer 1998;83(5):1012-21.
1998: Alice C Chiu; Steven I Sherman
Effects of pharmacological fiber supplements on levothyroxine absorption.
Thyroid : official journal of the American Thyroid Association 1998;8(8):667-71.
1997: Alice C Chiu; Ebrahim S Delpassand; Steven I Sherman
Prognosis and treatment of brain metastases in thyroid carcinoma.
The Journal of clinical endocrinology and metabolism 1997;82(11):3637-42.
1997: Steven I Sherman; Matthew D Ringel; M J Smith; Helen A Kopelen; William A Zoghbi; Paul W Ladenson
Augmented hepatic and skeletal thyromimetic effects of tiratricol in comparison with levothyroxine.
The Journal of clinical endocrinology and metabolism 1997;82(7):2153-8.
1996: Steven I Sherman; LISA SIMONSON; Paul W Ladenson
Clinical and socioeconomic predispositions to complicated thyrotoxicosis: a predictable and preventable syndrome?
The American journal of medicine 1996;101(2):192-8.
1994: Steven I Sherman; E T Tielens; Paul W Ladenson
Sucralfate causes malabsorption of L-thyroxine.
The American journal of medicine 1994;96(6):531-5.
1994: Steven I Sherman; E T Tielens; SAMUEL SOSTRE; Moody D Wharam; Paul W Ladenson
Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma.
The Journal of clinical endocrinology and metabolism 1994;78(3):629-34.
1994: E T Tielens; Steven I Sherman; Ralph Hruban; Paul W Ladenson
Follicular variant of papillary thyroid carcinoma. A clinicopathologic study.
Cancer 1994;73(2):424-31.
1992: Steven I Sherman; Paul W Ladenson
Organ-specific effects of tiratricol: a thyroid hormone analog with hepatic, not pituitary, superagonist effects.
The Journal of clinical endocrinology and metabolism 1992;75(3):901-5.
1992: Paul W Ladenson; Steven I Sherman; Kenneth L Baughman; P E Ray; Arthur M Feldman
Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(12):5251-5.
1992: Steven I Sherman; Paul W Ladenson
Octreotide therapy of growth hormone excess in the McCune-Albright syndrome.
Journal of endocrinological investigation 1992;15(3):185-90.
1991: Steven I Sherman; Paul W Ladenson
Percutaneous transluminal coronary angioplasty in hypothyroidism.
The American journal of medicine 1991;90(3):367-70.